Found 4 matching trials
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
PHASE1The goal of this clinical trial is to characterize to understand the effect...
Location
Stanford University
Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
PHASE1The goal of this phase I/II clinical trial is to compare B-cell depletion b...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin
A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis
PHASE1The goal of this study is to test a drug called KYV-101 in people who have ...
Status
Active Not Recruiting
Location
University of California, San Francisco, Multiple Sclerosis Center
Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis
PHASE1The goal of this phase I/II clinical trial is to investigate anti-CD 19 chi...
Location
Multiple Locations